4,8-Dibromobenzo[1,2-c:4,5-c']difuran-1,3,5,7-tetraone, 95.0%, 1g

GC capillary column ROTI®Cap-5, 10 m, 0.53 mm, 2.00 µm, 1 Piece(s)

N-[2-Methyl-2-(2-phenyloxazol-4-yl)propyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]benzaMide, 50mg

3-(3-Oxo-2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)propanenitrile, 97%, 10g

4-Chloro-1,3-phenylenediamine>98.0%(GC)(T)25g

(R)-1-(4-Benzyl-2-thioxothiazolidin-3-yl)ethanone, 98%, 250mg

(S)-5-Amino-3-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid, 95+%, 100mg

6-Bromo-1,1,4,4,7-pentamethyl-1,2,3,4-tetrahydro-naphthalene, 95.0%, 100g

1-(3-Bromopropyl)-4-methylbenzene, 95%, 500mg

Pyren-1-ylboronic acid, 95.0%, 5g

tert-Butyl 2,2-difluoro-3-(methacryloyloxy)pentanoate, 95.0%, 25g

5-(1H-Pyrazol-4-yl)isophthalic acid, 97%, 1g

1-BOC-3-(3-ISOPROPYL-1,2,4-OXADIAZOL-5-YL)PIPERIDINE, 97.0%, 250mg